Custom service

Peptide-Polymer Conjugation

Attach peptides to synthetic polymers to tune half-life, solubility or valency

Turnaround: 4–7 weeksTypical scale: 0.1–50 mg conjugate per batchChemistry options: PEGylation through maleimide and aldehyde handles; end-group coupling on RAFT-made polymers; grafting-to and grafting-from architecture control

The service is built around PEGylation through maleimide and aldehyde handles. Depending on the molecule we may move to end-group coupling on RAFT-made polymers or grafting-to and grafting-from architecture control to improve stability, loading or yield, and every batch is released with polymer conjugate with architecture and loading characterization.

Because Peptide-Polymer Conjugation projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.

Long-circulating imaging and delivery constructs

Multivalent display of binding motifs

GMP polymer–peptide drug substance for clinical supply

Conjugates whose payload cannot tolerate aqueous coupling conditions

Every conjugation batch is documented from vial to vial: carrier lot, payload lot, reagent lots, reaction conditions and purification chromatograms. The release package contains the loading ratio measured by an orthogonal method (UV, ICP-MS or amino-acid analysis), identity by mass spectrometry where the conjugate permits it, and residual-free-payload data.

Service Highlights

  • PEGylation through maleimide and aldehyde handles as the default route, with end-group coupling on RAFT-made polymers held as a proven fallback
  • Grafting-to and grafting-from architecture control worked into the design where the application requires it
  • Carrier and payload compatibility screened in a small feasibility batch before full material is committed
  • Analytical confirmation of every intermediate before the final release
  • Unreacted payload driven below the detection limit of the release assay before purification is closed
  • Polymer conjugate with architecture and loading characterization delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Scope & design

    We review the payload, the carrier and the intended assay or study, and propose between PEGylation through maleimide and aldehyde handles and end-group coupling on RAFT-made polymers as candidate routes.

  2. Feasibility screen

    A milligram-scale screen compares loading, residual payload and activity across the candidate conditions.

  3. Production conjugation

    The selected condition is executed at project scale with in-process sampling at fixed time points.

  4. Purification

    Size-exclusion, dialysis or magnetic separation removes free payload and by-products.

  5. Characterization & release

    Identity, loading ratio and functional activity are measured against the agreed specification.

  6. Documentation & hand-off

    Polymer conjugate with architecture and loading characterization is packaged with the full batch record, released for shipment after QC sign-off.

Specifications & timeline

Turnaround
4–7 weeks
Typical scale
0.1–50 mg conjugate per batch
Chemistry options
PEGylation through maleimide and aldehyde handles; end-group coupling on RAFT-made polymers; grafting-to and grafting-from architecture control
Deliverable
Polymer conjugate with architecture and loading characterization
QC package
HPLC/SEC trace, MALDI-TOF or ESI-MS, UV/Vis or ICP-MS loading ratio
Shipping
Blue ice or dry ice as the payload requires, with a cold-chain manifest

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.